Form 4: Glucotrack Director Robert Fischell Reports Share Acquisitions
SEC Form 4 Filing
Director Robert Fischell reports acquisitions of Glucotrack, Inc. common stock in a Form 4 filing.
Summary
- Robert Fischell, a director of Glucotrack, Inc., filed a Form 4 disclosing acquisitions of common stock.
- The transactions include acquisitions on August 24, 2021, April 8, 2024, and March 26, 2025.
- The filing reflects adjustments for 1-for-5 and 1-for-20 reverse stock splits implemented in May 2024 and February 2025, respectively.
- Following the reported transactions, Fischell beneficially owns 2,045 shares of Glucotrack common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The director's stock acquisitions could be interpreted positively, but without further context, it's difficult to gauge the overall impact.
Positives
- A director increasing their holdings can be seen as a positive signal.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 08/24/2021 | Acquisition of 318 shares of common stock |
| 04/08/2024 | Acquisition of 229 shares of common stock |
| 05/17/2024 | 1-for-5 reverse stock split implemented |
| 02/25/2025 | 1-for-20 reverse stock split implemented |
| 03/04/2025 | Date of Power of Attorney execution |
| 03/26/2025 | Acquisition of 1,498 shares of common stock |
| 03/28/2025 | Date of Form 4 signature |
Keywords
Form 4, beneficial ownership, stock acquisition, Robert Fischell, Glucotrack, GCTK, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.